Coya Therapeutics, Inc. Current Assets
Coya Therapeutics, Inc. (COYA) had Current Assets of $47.06 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $47.06M.
- 2026-03-31: Assets, Current $53.26M.
- 2025-12-31: Assets, Current $49.94M.
- 2025-09-30: Assets, Current $32.02M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $47.06M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $53.26M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $49.94M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $32.02M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $33.43M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $38.37M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $44.31M 10-K · filed 2026-03-16 |
| 2024-09-30 | $35.51M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $39.89M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $37.33M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $41.20M 10-K · filed 2025-03-18 |
| 2023-09-30 | $11.82M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $14.39M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $17.33M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $7.18M 10-K · filed 2024-03-19 |
| 2021-12-31 | $4.58M 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |